Ricardo E Bruges Maya

5PUBLICATIONS
30CO-AUTHORS
Tumour immunologyOncology and carcinogenesis not elsewhere classifiedMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2026
Real-World Outcomes of Immune Checkpoint Inhibitors in Melanoma, Including Acral and Mucosal Subtypes: A Retrospective Cohort Study From a Latin American Center.

|Jun 06, 2026
Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus.

|Apr 30, 2026
Clinical and prognostic factors in pleural mesothelioma: insights from a Latin American cohort.

|Apr 01, 2026
National Delphi consensus on perioperative and locally advanced NSCLC management in Colombia.

Ricardo Bruges Maya, Milton Lombana, Carlos Andres Carvajal-Fierro

|Sep 13, 2025
Diagnostic accuracy of next-generation sequencing (NGS) for identifying actionable mutations in advanced non-small cell lung cancer: Systematic Review and Meta-Analysis.

Nicolás Téllez Castillo, Ana M Goyeneche-García, Luisa M Montoya Quesada

Pageof 1

Frequent Collaborators

1 joint publications

Vaneza Avila-Rodriguez

1 joint publications

Juan Manuel Vasquez

1 joint publications

Luisana Molina-Pimienta

1 joint publications

Carlos Bonilla-Gonzalez